Skip to main content

The European Journal of Health Economics

Ausgabe 3/2011

Inhalt (9 Artikel)

Editorial

To model or not to model: lessons from two vaccinations

Livio Garattini, Anna Padula

Original Paper

Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy

Eberhard Wille, Jürgen Scholze, Eduardo Alegria, Claudio Ferri, Sue Langham, Warren Stevens, David Jeffries, Kerstin Uhl-Hochgraeber

Original Paper

Utilities and disutilities for attributes of injectable treatments for type 2 diabetes

Kristina S. Boye, Louis S. Matza, Kimberly N. Walter, Kate Van Brunt, Andrew C. Palsgrove, Aodan Tynan

Open Access Original Paper

Practical issues in handling data input and uncertainty in a budget impact analysis

M. J. C. Nuijten, T. Mittendorf, U. Persson

Open Access Original Paper

Deriving reference values and utilities for the QoL-AGHDA in adult GHD

J. J. V. Busschbach, B. H. R. Wolffenbuttel, L. Annemans, W. J. Meerding, M. Kołtowska-Häggström

Original Paper

Economic evaluation of irbesartan in combination with hydrochlorothiazide in the treatment of hypertension in Greece

Nikos Maniadakis, Mattias Ekman, Vasilios Fragoulakis, Vasiliki Papagiannopoulou, John Yfantopoulos

Open Access Original Paper

Reimbursement of pharmaceuticals: reference pricing versus health technology assessment

Michael Drummond, Bengt Jönsson, Frans Rutten, Tom Stargardt

Original Paper

Health care costs and their predictors of inflammatory bowel diseases in Germany

Anne Prenzler, Bernd Bokemeyer, J.-Matthias von der Schulenburg, Thomas Mittendorf